title: Measures of the inflammatory response in cryptogenic fibrosing alveolitis.
abstract: Cryptogenic fibrosing alveolitis (CFA) is characterized by interstitial fibrosis and parenchymal inflammation. Eleven patients with CFA (10 proved by lung biopsy) were followed over 2 yr using clinical symptoms, radiographic change, and pulmonary function tests to adjust their treatment. Lung lavage, positron camera (PET) measurements of regional extravascular lung density (Dev), pulmonary blood volume (Vb), and the metabolic rate for 18F-deoxyglucose (MRglc), clearance of 99mTc-diethylenetriaminepentacetate (99mTc-DTPA) aerosol, and lung uptake of 67Ga were measured initially and at the end of the first year to give a profile of the inflammatory response. Compared with normal subjects, there was an increased percentage of neutrophils and eosinophils in the lung lavage, increased Dev (p less than 0.002) with no significant difference in Vb, increased MRglc (p less than 0.02), 99mTc-DTPA clearance (p less than 0.002), and 67Ga uptake (p less than 0.02). The smallest increases in Dev were seen in the two patients with most destruction shown by lung biopsy. There were inverse correlations between Dev and both FVC and TLC, but a direct correlation between Vb and transfer factor. 99mTc-DTPA clearance changed concordantly with clinical status and radiographic and respiratory function changes during the first year. If glucose utilization (MRglc) remained in the normal range between the initial and first yearly assessment, the patient improved or remained stable during the second year as shown by clinical status and radiographic and respiratory function measurements. If it rose or remained high, the patient's condition deteriorated.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Cardiothoracic Institute, Brompton Hospital, London, United Kingdom.
authors.forename: C F
authors.initials: CF
authors.lastname: Pantin
authors.forename: S O
authors.initials: SO
authors.lastname: Valind
authors.forename: M
authors.initials: M
authors.lastname: Sweatman
authors.forename: R
authors.initials: R
authors.lastname: Lawrence
authors.forename: C G
authors.initials: CG
authors.lastname: Rhodes
authors.forename: L
authors.initials: L
authors.lastname: Brudin
authors.forename: A
authors.initials: A
authors.lastname: Britten
authors.forename: J M
authors.initials: JM
authors.lastname: Hughes
authors.forename: M
authors.initials: M
authors.lastname: Turner-Warwick
mesh_terms: D000368:Aged; D001810:Blood Volume; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology; D005260:Female; D005708:Gallium / Q000378:metabolism; D005710:Gallium Radioisotopes; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008168:Lung / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D011652:Pulmonary Circulation; D011658:Pulmonary Fibrosis / Q000000981:diagnostic imaging / Q000473:pathology* / Q000503:physiopathology; D012016:Reference Values; D012129:Respiratory Function Tests; D014055:Tomography, Emission-Computed; D015091:beta-Alanine / Q000031:analogs & derivatives
chemical_list: D005710:Gallium Radioisotopes; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; C054752:technetium TC 99m 2,3-diaminopropionic acid; D015091:beta-Alanine; D005708:Gallium; D005947:Glucose